Fact CheckerSign in

NCT07649187Completed

Depressive Tendency and Counseling Outcomes in Thymoma-Associated MG

Association of Baseline Depressive Tendency With Post-Counseling Clinical Status in Patients With Thymoma-Associated Myasthenia Gravis

Source: ClinicalTrials.gov · Last updated 17 Jun 2026

Brief summary (registry, in English)

This study aimed to examine whether baseline depressive tendency independently predicts post-counseling clinical outcomes in patients with thymoma-associated MG. This single-group pre-post exploratory pilot study enrolled patients with thymoma-associated MG who received eight sessions of Gestalt-oriented psychological counseling. Depressive tendency was defined as a baseline Patient Health Question-naire-9 (PHQ-9) score ≥10. Clinical outcomes, including the Myasthenia Gravis Activities of Daily Living scale (MG-ADL), Myasthenia Gravis Quality of Life 15-item scale (MG-QoL15), and mental BMI (mBMI), were assessed before and after the intervention. Multivariable regression analyses were performed to evaluate whether baseline clinical severity independently predicted post-intervention outcomes after sequential adjustment for baseline scores, age, and sex.

Status (registry)
Completed
Study type
Interventional
Enrollment
19 (actual)
First submitted
4 Dec 2025
Start date
1 Jan 2024
Primary completion date
31 Dec 2025
Lead sponsor
Ming-Hsing Chang
NCT number
NCT07649187

What you commit to

  • Study type: Interventional
  • Participants enrolled: 19
  • From 1 Jan 2024 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Failure to confirm thymoma on postoperative pathological examination
  • The presence of conditions that could compromise verbal communication or regular participation in counseling sessions, such as significant traumatic brain injury, severe psychiatric disorders, or cognitive impairment

Other

  • The absence of a confirmed diagnosis of myasthenia gravis
  • Inability to communicate adequately in Mandarin, Taiwanese, English, or written form

Who the study is looking for

  • A confirmed diagnosis of MG associated with thymoma and prior completion of surgical treatment
  • Age ≥ 20 years
  • Ability to communicate clearly and provide reliable responses
  • Absence of cognitive impairment or severe psychiatric illness that could interfere with participation
  • Willingness to participate in the study with provision of written informed consent

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shin Kong Wu Ho Su Memorial Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.